Four companies are expected to have UK marketing authorisations for generic weight loss medicines following the expiry of liraglutide's patent
The British Generic Manufacturers...
One of the most promising applications of AI lies in personalised medicines. Dr. Yasmin Karsan expounds…
Artificial Intelligence (AI) is an incredible tool that is...
At least four companies are expected to have UK marketing authorisations for generic weight loss medicinesÂ
With Novo Nordisk's patent protection for liraglutide now expired,...
GlobalData underscores the urgent need for affordable biosimilars to meet the demands of a growing number of HER2+ breast cancer patients
The ongoing legal battle...